良性与恶性疾病中血浆β2-微球蛋白的测定（作者译）
[Determination of plasmatic beta2-microglobulin in benign and cancerous diseases (author's transl)].
作者信息
Calderoli H, Koehl C, Abecassis J, Schoenahl C, Meyer C, Hollender L F
出版信息
Pathol Biol (Paris). 1978 Sep;26(6):359-60.
PMID:83585
Abstract
The authors report on their experience of the beta2-microglobulin dosage in cancerous diseases and note an increase of its rate in 47% of the cases. A comparative study with certain benign diseases of the digestive tract shows that this dosage proves to be interesting.
摘要
作者报告了他们在癌症疾病中检测β2-微球蛋白剂量的经验，并指出在47%的病例中其水平有所升高。一项针对某些消化道良性疾病的对比研究表明，这种剂量检测结果很有意义。
相似文献
1
[Determination of plasmatic beta2-microglobulin in benign and cancerous diseases (author's transl)].良性与恶性疾病中血浆β2-微球蛋白的测定（作者译）
Pathol Biol (Paris). 1978 Sep;26(6):359-60.
2
[Determination of plasma beta 2 microglobulin in malignant and benign digestive diseases].[恶性与良性消化系统疾病中血浆β2微球蛋白的测定]
Nouv Presse Med. 1978 Mar 4;7(3):758-9.
3
4
5
[Determination of beta2-microglobulin in breast, lung, colorectal and ENT carcinoma (author's transl)].乳腺癌、肺癌、结直肠癌及耳鼻喉癌中β2-微球蛋白的测定（作者译）
Pathol Biol (Paris). 1978 Sep;26(6):351-2.
6
[Serum beta2-microglobulin and carcino-embryonic antigen in cancerous patients. A preliminary study of 258 cases (author's transl)].癌症患者血清β2-微球蛋白和癌胚抗原。258例初步研究（作者译）
Pathol Biol (Paris). 1978 Sep;26(6):363-5.
7
8
9
[The interest of beta2-microglobulin in the cancer (author's transl)].β2-微球蛋白在癌症中的意义（作者译）
Pathol Biol (Paris). 1978 Sep;26(6):343-4.
10
[Clinical value of the combined determination of the plasma concentrations of beta 2m and of CEA in the primary diagnosis and the control of radical surgery of adenocarcinoma of the gastrointestinal tract (author's transl)].β2m与CEA血浆浓度联合检测在胃肠道腺癌初步诊断及根治性手术疗效监测中的临床价值（作者译）
Klin Wochenschr. 1980 Dec 1;58(23):1313-7. doi: 10.1007/BF01478140.
Zotero 插件